ABSTRACT
El dengue es una enfermedad viral aguda, endemo-epidémica, trans-mitida por la picadura de las hembras de mosquitos del género Aedes aegypti. Constituye hoy la arbovirosis más importante a nivel mundial en términos de morbilidad, mortalidad e impacto económico. Para el abordaje práctico de este síndrome, la OMS a través de un gru-po denominado DENCO (Dengue Control), lo clasificó en dengue con y sin signos de alarma contribuyendo a un diagnóstico y tratamiento más oportunos. Es una enfermedad compleja en sus manifestaciones, sin tratamiento específico. La mortalidad por dengue es evitable en la mayoría de los casos siempre y cuando se intervenga de manera correcta, oportuna. Está estrechamente relacionada con la calidad en la atención del pa-ciente. Compartimos nuestras estrategias de intervención en relación con el trabajo realizado para la atención de los pacientes durante los brotes en la provincia de Santa Fe, Argentina
Dengue fever is an acute, endemo-epidemic, viral disease transmitted by the bite of female mosquito Aedes aegypti. Today is the most important arbovirus globally in terms of morbidity, mortality and economic impact For the practical approach , WHO through a group called DENCO (Dengue Control), ranked it in Dengue and without warning signs contributing to a diagnosis and treatment more appropriate Is a complex disease in its manifestations , without specific treatment .Dengue mortality is avoidable in most cases if you intervene in correct, timely manner and is closely related to the quality of care of the patient. We share in this work our intervention strategies in relation to the work done for the care of patients during outbreaks in the province of Santa Fe, Argentina
Subject(s)
Humans , Male , Female , Dengue/prevention & control , Dengue/epidemiology , Dengue VirusABSTRACT
As a consequence of YF outbreaks that hit Brazil, Argentina, and Paraguay in 2008-2009, a significant demand for YF vaccination was subsequently observed in Argentina, a country where the usual vaccine recommendations are restricted to provinces that border Brazil, Paraguay, and Bolivia. The goal of this paper is to describe the adverse events following immunization (AEFI) against YF in Argentina during the outbreak in the northeastern province of Misiones, which occurred from January 2008 to January 2009. During this time, a total of nine cases were reported, almost two million doses of vaccine were administered, and a total of 165 AEFI were reported from different provinces. Case study analyses were performed using two AEFI classifications. Forty-nine events were classified as related to the YF vaccine (24 serious and 1 fatal case), and 12 events were classified as inconclusive. As the use of the YF 17D vaccine can be a challenge to health systems of countries with different endemicity patterns, a careful clinical and epidemiological evaluation should be performed before its prescription to minimize serious adverse events.
